Literature DB >> 10740823

HTLV-I Tax and cell cycle progression.

C Neuveut1, K T Jeang.   

Abstract

Human T-cell leukemia virus type I (HTLV-I) is the etiological agent for adult T-cell leukemia (ATL) and various human myopathies/neuropathies. HTLV-I encodes a 40 kDa phosphoprotein, Tax, which has been implicated in cellular transformation. In similarity with several other oncoproteins such as Myc, Jun, and Fos, Tax is a transcriptional activator. How Tax mechanistically dysregulates the cell cycle remains unclear. Recent findings from us and others have shown that Tax targets key regulators of G1/S and M progression such as p16INK4a, cyclin D1, cyclin D3-cdk, and the mitotic spindle checkpoint apparatus. Thus, Tax influences the progression of cells in various phases of the cell cycle. In this regard, we will discuss three distinct mechanisms through which Tax affects cell-cycling: a) through direct association Tax can abrogate the inhibitory function of p16INK4a on the G1-cdks, b) Tax can also directly influence cyclin D-cdk activities by a protein-protein interaction, and c) Tax targets the HsMAD1 mitotic spindle-assembly checkpoint protein. Through these varied routes, the HTLV-I oncoprotein dysregulates cellular growth controls and engenders a proclivity of cells toward a loss of DNA-damage surveillance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740823     DOI: 10.1007/978-1-4615-4253-7_14

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  19 in total

1.  Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein.

Authors:  Jean-Marie Peloponese; Kerstin Haller; Akiko Miyazato; Kuan-Teh Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

2.  Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosis.

Authors:  Min-Hui Liang; Thomas Geisbert; Yao Yao; Steven H Hinrichs; Chou-Zen Giam
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I).

Authors:  Björn Albrecht; Celine D D'Souza; Wei Ding; Susheela Tridandapani; K Mark Coggeshall; Michael D Lairmore
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  CREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein.

Authors:  K V Kibler; K T Jeang
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin.

Authors:  W Ding; B Albrecht; R Luo; W Zhang; J R Stanley; G C Newbound; M D Lairmore
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.

Authors:  W Zhang; J W Nisbet; B Albrecht; W Ding; F Kashanchi; J T Bartoe; M D Lairmore
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.

Authors:  S Okazaki; R Moriuchi; N Yosizuka; K Sugahara; T Maeda; I Jinnai; M Tomonaga; S Kamihira; S Katamine
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

Review 8.  Human T-cell leukemia virus type 1 Tax and cellular transformation.

Authors:  Jean-Marie Peloponese; Takao Kinjo; Kuan-Teh Jeang
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 9.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

10.  Human T-lymphotropic virus type 1 oncoprotein tax promotes unscheduled degradation of Pds1p/securin and Clb2p/cyclin B1 and causes chromosomal instability.

Authors:  Baoying Liu; Min-Hui Liang; Yu-liang Kuo; Wei Liao; Imre Boros; Tami Kleinberger; Jan Blancato; Chou-Zen Giam
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.